Targeting the TRIM21-PD-1 axis potentiates immune checkpoint blockade and CAR-T cell therapy
2025 · Molecular Therapy · 14 citations
https://doi.org/10.1016/j.ymthe.2025.01.047
J
Jie Shi
Wuhan University(CN)
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
10
Papers
148
Citations
4
h-index
3
i10-index
Jie Shi is an academic researcher from Wuhan University. The author has contributed to research in topics: Hepatocellular Carcinoma Treatment and Prognosis & Cancer Immunotherapy and Biomarkers & Pancreatic and Hepatic Oncology Research. The author has an h-index of 4, co-authored 9 publications.
ORCID: 0009-0002-7870-0579Papers by this author
worksThe A-to-I editing of KPC1 promotes intrahepatic cholangiocarcinoma by attenuating proteasomal processing of NF-κB1 p105 to p50
2022 · Journal of Experimental & Clinical Cancer Research · 12 citations
https://doi.org/10.1186/s13046-022-02549-1
A rare case of Alveolar Soft-Part Sarcoma in the Uterine cervix
2025 · Diagnostic Pathology · 0 citations
https://doi.org/10.1186/s13000-025-01620-7
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat